Lyra Therapeutics, Inc. (LYRA)
$0.19+0.00%Close
BUYRECOVERY · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $337,228
- Beta
- 0.70
- P/E (TTM)
- -0.01
- Short % float
- 0.30%
- Days to cover
- 4.1
- SI change
- -0.3%
- 1W
- +0.00%
- 1M
- -5.00%
- vs SPY 1W
- +0.14%
- vs SPY 1M
- -7.51%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on LYRA?
- LOPJLB’s latest quantitative signal on Lyra Therapeutics, Inc. (LYRA) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is LYRA in?
- Lyra Therapeutics, Inc. (LYRA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Lyra Therapeutics, Inc. (LYRA) do?
- Lyra Therapeutics, Inc. operates as a clinical-stage biotechnology company, primarily focused on the creation and commercialization of anti-inflammatory treatments for individuals suffering from chronic rhinosinusitis (CRS). The company's unique technological approach allows for the direct delivery of therapeutic agents to the targeted tissue, ensuring prolonged efficacy from a singular dose. I…